Half-life profile

MDA half-life calculator

Educational first-order elimination curve using an approximate half-life estimate. This is not medical advice and does not predict impairment or laboratory outcomes.

Category: entactogen · Updated: 2026-01-18

Now estimated in body: 18.95 mg(18.9% of starting amount)Half-life used: 10.0 h

Pharmacokinetics at a glance

Summary Educational half-life profile for MDA (entactogen). Uses a mean half-life of 10.0 hours for a simplified curve.
Mean half-life 10 hours

Summary: Educational half-life profile for MDA (entactogen). Uses a mean half-life of 10.0 hours for a simplified curve.

Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.

Notes

Overview

MDA is listed here as entactogen. Entactogens are substances associated with heightened empathy and mood effects. Half-life estimates vary across studies and are sensitive to sampling windows and analytic approach.

This page provides an educational visualization of exponential decay based on a single half-life estimate. It is not medical advice.

Half-life used on this page

HalfLifeDB uses a mean half-life of 10.0 hours to generate the curve below. The curve shows a relative amount remaining in a simplified model.

Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.

What the curve represents

The calculator assumes a one-compartment, first-order elimination model after a single starting amount. In that model, the remaining amount halves every half-life interval. The curve is best used to understand the shape of exponential decline.

Why published half-life values differ

Even when a study reports a single half-life number, values can differ across studies and people. Common drivers include:

  • Route and formulation: immediate vs extended release, oral vs inhaled vs injected, and co-administered ingredients.
  • Study design: sampling window, analytic sensitivity, and how the terminal phase is defined.
  • Individual biology: age, genetics, body composition, and liver and kidney function.
  • Interactions: other medications and substances can inhibit or induce metabolism.

How to use this page

  • Use the calculator to visualize how quickly a half-life process decays over time.
  • Use the source links to see the context for the half-life estimate.
  • Treat this curve as a conceptual model, not a personal prediction.

What this page does not do

  • It does not provide dosing guidance or treatment advice.
  • It does not estimate impairment or functional safety.
  • It does not predict laboratory outcomes.

If you have questions about medication use or health decisions, consult a licensed clinician. In an emergency, contact local emergency services.

Read the full medical disclaimer and editorial policy.